Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study.

Elisabeth L ZeilingerC OppenauerMatthias KnefelV KantorC SchneckenreiterS LubowitzkiK KrammerC PopingerA KittaL KumF AdamidisM UnseldE K MaselT FürederS Zöchbauer-MüllerR BartschM RadererG PragerM T KrauthW R SperrE PorpaczyP B StaberP ValentAlexander Gaiger

Published in: Epidemiology and psychiatric sciences (2022)

The prevalence of anxiety and depression is high in cancer patients. Type of cancer is an important predictor for anxiety and depressive symptoms, with lung and brain cancer patients being highly burdened. Considering a personalised medicine approach, physicians should take into account the high prevalence of psychiatric comorbidities and include psychiatric consultations in the treatment plan.

Keyphrases

papillary thyroid
depressive symptoms
risk factors
mental health
squamous cell
primary care
lymph node metastasis
physical activity
sleep quality
white matter
subarachnoid hemorrhage
brain injury
blood brain barrier
cerebral ischemia